CleanCap® M6 IVT Kit and mRNA ModTail™ Kit Bundle
Description
TriLink’s CleanCap® M6 IVT Kit, High Yield – (K-7453):
TriLink’s CleanCap® M6 IVT Kit, High Yield is a comprehensive solution for mRNA synthesis by in vitro transcription (IVT) with CleanCap® co-transcriptional capping. The kit components are sufficient for 20 x 20 µL or 125 x 20 µL reactions depending on the kit size and following our recommended IVT protocol with co-transcriptional capping. When used with the pulse feed protocol, each 20 µL reaction typically produces 160–200 µg of capped mRNA, corresponding to approximately 3.2–4 mg per 20-reaction kit (K-7453-20) and 20–25 mg per 125-reaction kit (K-7453-125).
TriLink’s mRNA ModTail™ Kit supplies our proprietary reagent and enzyme mixes for the installation of a poly(A) tail modification on purified mRNA. The kit components are sufficient to convert 2.5 mg of purified mRNA to ModTail™ mRNA following our included protocol.
Both CleanCap® IVT Kit and mRNA ModTail™ Kit can be used independently as well.
The CleanCap® M6 IVT Kit, High Yield kit is designed for cumulative gains in yield, quality, and expression. Key benefits of TriLink’s IVT kits compared to others with enzymatic or other co-transcriptional capping include:
- Time and cost savings - Co-transcriptional capping protocol for high-yield mRNA synthesis with >95% capping efficiency in a single tube, reducing steps and hands-on time
- High protein expression - Increase protein expression by ≥30% with CleanCap M6 versus its predecessors and enzymatic capping
- Increased mRNA yield - Optimized CleanCap M6 IVT with a supplementary pulse-feed protocol for up to 10 mg/mL yield
- Ultra-low double-stranded RNA (dsRNA) levels - Up to 85% dsRNA reduction using CleanScribe™ RNA Polymerase, in place of wild-type T7 RNA polymerase, in CleanCap M6 IVT
- Enhanced mRNA performance - Achieve high protein expression and low inflammatory responses from mRNA synthesized with CleanCap M6, CleanScribe RNA polymerase, and N1-methylpseudouridine
ModTail™ kit’s key features and benefits include:
- Enhanced protein expression and duration - ModTail™ technology increases mRNA stability and protein expression in vivo
- High integration efficiency - the protocol results in ≥90% integration efficiency for most constructs
- Broad compatibility - with most mRNA constructs regardless of cap analog, base modification, or tail length
- Easy to use - No change to delivery process or impact on critical quality attributes such as integrity, capping, and dsRNA
This bundle includes:
Important note:
- Please refer to the individual product webpages above for kit specific information and FAQs.
Product attributes
| Catalog No. | K-7453 |
| Application | In vitro Transcription, co-transcriptional capping, mRNA synthesis |
| Cap | AG Start, Cap 1 |
| Cap Analogs | CleanCap® M6 |
| Product Grade | RUO |
| Reaction Size | 20 x 20 µL (K-7453-20) 125 x 20 µL (K-7453-125) |
| Recommended Storage | -15°C to -25°C |
mRNA ModTail™ Kit
| Catalog No. | K-2200-S |
| Application | enhanced protein expression and duration, CRISPR/Car-T, RNA therapeutics |
| Components | ModTail™ Enzyme Mix and ModTail™ Reaction Mix |
| Product type | Poly(A) tail modification kit |
| Reaction size | Converts up to 2.5 mg of purified mRNA |
| Recommended Storage | -15°C to -25°C |
Technical documents
- Safety Data Sheet Look-up open_in_new
- N-7453 Product Insert open_in_new
- K-7413 CleanCap IVT kit manual open_in_new
- K-2200 mRNA ModTail™ Kit Product Insert open_in_new
Certificate of analysis
- Certificate of Analysis (CoA) open_in_new
Intellectual property
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission from TriLink No license under any patent or other intellectual property right of TriLink or its licensors is granted or implied by the purchase unless otherwise provided in writing.
CleanCap capping technology
For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. For additional licensing restrictions, please see the license agreement at trilinkbiotech.com/cleancap-research-license. Patents and patent pending, see trilinkbiotech.com/legal-notices.
ModTail™ technology
For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. For additional licensing restrictions, please see the license agreement at trilinkbiotech.com/modtail-research-license. Patents and patents pending, see (trilinkbiotech.com/legal-notices)[https://trilinkbiotech.com/legal-notices].
Related products
-
CleanCap® M6 EGFP mRNA (N1MePsU) L-8101open_in_new
-
CleanCap® M6 FLuc mRNA (N1MePsU) L-8102open_in_new
-
CleanCap® M6 Cas9 mRNA (N1MePsU) L-8106open_in_new
-
CleanCap® AG 3' OMe CleanScript™ IVT Kit K-7413open_in_new
-
CleanCap® M6 IVT Kit, High Yield K-7453open_in_new
-
CleanCap® M6 EGFP ModTail™ mRNA (N1MePsU) L-8101Aopen_in_new
-
CleanCap® M6 FLuc ModTail™ mRNA (N1MePsU) L-8102Aopen_in_new
-
CleanCap® M6 Cas9 ModTail™ mRNA (N1MePsU) L-8106Aopen_in_new
-
CleanCap® M6 IVT Kit and mRNA ModTail™ Kit Bundle (sold as Each)SKU: K-9653-20S$980.00